...
首页> 外文期刊>Angiology: the Journal of Vascular Diseases >Increased urinary albumin excretion rates can be a marker of coexisting coronary artery disease in patients with peripheral arterial disease.
【24h】

Increased urinary albumin excretion rates can be a marker of coexisting coronary artery disease in patients with peripheral arterial disease.

机译:尿白蛋白排泄率升高可能是外周动脉疾病患者并存冠状动脉疾病的标志。

获取原文
获取原文并翻译 | 示例

摘要

Coexisting coronary artery disease (CAD) is an important cause of morbidity and mortality in patients with peripheral arterial disease (PAD). Clinical evaluation and noninvasive tests have some important limitations for the detection of CAD in patients with PAD. The purpose of this study was to investigate whether urinary albumin excretion (UAE) was a sign of atherosclerotic involvement of coronary arteries in patients with PAD. Our study consisted of 65 consecutive patients (56 men, 9 women, mean age; 59.7+/-7.9 years) with PAD who underwent coronary angiography. Urinary albumin excretion was measured in 24-hour urine samples by immunoprecipitation technique. PAD was defined as the presence of > or 50% stenotic lesions in at least 1 of the iliac, femoral, popliteal, tibialis anterior, tibialis posterior, or peroneal arteries. CAD was defined as > or =25% diameter stenosis in at least 1 coronary artery. Patients without any coronary lesions were accepted as having normal coronaries. Age, sex, distributions of coronary risk factors, and UAE rates were compared between patients with and without CAD. Mean UAE was 17.9+/-15.6 mg/day in the total population. Thirty-seven percent of patients had CAD, and 63% had no coronary lesion. UAE rates were 22.33+/-18.74 and 15.32+/-13.01 mg/day in patients with CAD and those with normal coronary arteries, respectively (p = 0.021). Microalbuminuria was detected in 25% in patients with CAD and 12% in those without coronary artery lesions (p = 0.184). The difference was not statistically significant. The distributions of other risk factors and sex were not different between the 2 groups. These data suggest that in patients with PAD, urinary albumin excretion rates may be used to determine those with a high probability of CAD. Further studies are required to decide whether this noninvasive testing is appropriate in detecting high-risk patients.
机译:并存冠状动脉疾病(CAD)是外周动脉疾病(PAD)患者发病和死亡的重要原因。临床评估和无创检测对PAD患者CAD的检测有一些重要限制。这项研究的目的是调查尿液白蛋白排泄(UAE)是否是PAD患者冠状动脉粥样硬化受累的标志。我们的研究包括65例接受冠状动脉造影的PAD连续患者(56例男性,9例女性,平均年龄; 59.7 +/- 7.9岁)。通过免疫沉淀技术测量24小时尿液样本中尿白蛋白排泄量。 PAD定义为在1,股,al,胫前,胫后或腓动脉中至少有1个存在≥50%的狭窄病变。 CAD被定义为至少1条冠状动脉直径狭窄≥25%。没有任何冠状动脉病变的患者被认为具有正常冠状动脉。比较有和没有CAD的患者的年龄,性别,冠状动脉危险因素分布和阿联酋率。总人口中的平均阿联酋为17.9 +/- 15.6 mg / day。 37%的患者患有CAD,63%的患者没有冠状动脉病变。 CAD患者和冠状动脉正常患者的UAE发生率分别为22.33 +/- 18.74和15.32 +/- 13.01 mg /天(p = 0.021)。患有CAD的患者中检出微量白蛋白尿的比例为25%,而没有冠状动脉病变的患者中检出比例为12%(p = 0.184)。差异无统计学意义。两组其他危险因素和性别的分布无差异。这些数据表明,在患有PAD的患者中,尿白蛋白排泄率可用于确定那些CAD可能性高的患者。需要进一步的研究来决定这种无创性检测是否适合检测高危患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号